Valuation: Physiomics Plc

Market Cap 2.15M 2.88M 2.57M 2.38M 4.06M 272M 4.1M 28.52M 11.19M 143M 10.82M 10.59M 456M P/E 2025
-2.67x
P/E 2026 -2.35x
Enterprise Value 1.73M 2.32M 2.07M 1.92M 3.27M 219M 3.31M 22.97M 9.01M 115M 8.71M 8.53M 367M EV / Sales 2025
1.14x
EV / Sales 2026 1.64x
Free-Float
74.27%
Yield 2025 *
-
Yield 2026 -

Last Transcript: Physiomics Plc

1 day-4.21%
1 week-4.21%
Current month-13.33%
1 month-4.21%
3 months-9.00%
6 months-4.21%
Current year+59.65%
1 week 0.45
Extreme 0.45
0.5
1 month 0.45
Extreme 0.45
0.55
Current year 0.25
Extreme 0.2525
0.8
1 year 0.25
Extreme 0.2525
0.8
3 years 0.25
Extreme 0.2525
2.1
5 years 0.25
Extreme 0.2525
7.25
10 years 0.25
Extreme 0.2525
32
Manager TitleAgeSince
Director of Finance/CFO 52 -
Chief Operating Officer - 30/06/2026
Corporate Officer/Principal - 30/08/2021
Director TitleAgeSince
Director/Board Member - 28/04/2026
Chairman 53 28/04/2026
Director/Board Member - 28/04/2026
Date Insider Type Main position Quantity % Market Cap. Importance
10/07/26 Buy

Director

3,000,000 0.6619%
10/07/26 Buy

Director

1,111,111 0.2452%
08/11/24 Buy

Chief Executive Officer

459,090 0.2259%
Change 5-day change 1-year change 3-year change Capi.($)
-4.21%-4.21%+16.67%-70.65% 2.88M
+1.15%+8.47%-8.40%+26.61% 131B
+1.20%+3.95%-0.80%+55.38% 83.31B
+2.19%+7.92%-29.38%-4.51% 49.86B
+2.16%+7.84%+11.86%+23.42% 43.94B
+0.50%+5.29%-15.54%+11.87% 35.05B
-0.26%+4.30%-24.68%-29.14% 21.29B
-0.55%+16.77%-23.64%-0.45% 20.54B
-0.94%+5.97%-23.25%+2.95% 20.13B
+1.42%+3.82%+15.56%+69.39% 17.23B
Average +0.27%+7.62%-8.16%+8.49% 42.2B
Weighted average by Cap. +1.09%+7.83%-9.15%+23.54%

Financials

2025 2026
Net sales 834K 1.12M 996K 922K 1.57M 105M 1.59M 11.05M 4.34M 55.42M 4.19M 4.1M 177M 1.06M 1.41M 1.26M 1.17M 1.99M 133M 2.01M 13.98M 5.49M 70.1M 5.3M 5.19M 223M
Net income -415K -556K -496K -459K -782K -52.49M -792K -5.5M -2.16M -27.59M -2.09M -2.04M -87.91M -697K -934K -832K -770K -1.31M -88.1M -1.33M -9.23M -3.62M -46.31M -3.5M -3.43M -148M
Net Debt -457K -612K -546K -505K -862K -57.8M -872K -6.06M -2.38M -30.38M -2.3M -2.25M -96.81M -419K -561K -500K -463K -789K -52.91M -798K -5.55M -2.18M -27.81M -2.1M -2.06M -88.63M
Projected Income Statement - Annual - Physiomics Plc
Logo Physiomics Plc
Physiomics PLC is a United Kingdom-based company, which provides consulting services to pharmaceutical companies in the areas of outsourced quantitative pharmacology and computational biology. The Company offer its services by utilizing its proprietary Virtual Tumour predictive software, industry standard tools (such as NONMEM and MATLAB), as well as developing bespoke models using the R programming language. Virtual Tumour is a predictive quantitative systems' pharmacology (QSP) model used worldwide by global pharmaceuticals to small biotech companies to support oncology Research and development (R&D). It is a semi-mechanistic model that incorporates an abstracted representation of the cell cycle, Deoxyribonucleic acid (DNA) damage/ repair and elements of the immune response. The Company is also developing its technology for use in the field of personalized medicine. The Company is focused on helping pharma and biotech clients.
Employees
11
Date Price Change Volume
22/10/26 GBX 0.4550 -4.21% 153,008
21/10/26 GBX 0.4750 0.00% 34
20/10/26 GBX 0.4750 0.00% 971,692
19/10/26 GBX 0.4750 0.00% 1,134,827
16/10/26 GBX 0.4750 0.00% 2,002,172

Annual profits - Rate of surprise

Rate of surprise - EPS - Annual - Physiomics Plc